Fibroblast growth factor 23 in patients with systemic lupus erythematosus : Association with inflammatory markers and left ventricular mass / Dina Ossama Abdelazim Abdelsalam ; Supervised Somaya Anwar Hussein , Nahla Naeem Mohamed , Mahmoud Elsayed Saraya
Material type:
- معامل النمو للخلية الليفية الأولية رقم ٢٣ في مرض الذئبة الحمراء: علاقة بدلالات الالتهاب و كتلة البطين الأيسر [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.32.Ph.D.2018.Di.F (Browse shelf(Opens below)) | Not for loan | 01010110078724000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.32.Ph.D.2018.Di.F (Browse shelf(Opens below)) | 78724.CD | Not for loan | 01020110078724000 |
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation
Background: The last decade has witnessed the discovery of a mutual relationship between inflammation and FGF23. FGF23 is recognized as an important offender in CKD patients. Beside its recognized role in vascular calcification, FGF23 was found to be significantly associated with different inflammatory markers, left ventricular hypertrophy, and increased mortality. SLE is an autoimmune disease characterized by a profound inflammatory status. Left ventricular hypertrophy and chronic kidney disease are frequently encountered in SLE patients. Objective: The aim of the study was to look for fibroblast growth factor blood level in Systemic Lupus Erythematosus (SLE) with and without lupus nephritis looking for its possible impact on the inflammatory and cardiovascular manifestations encountered in this disease
Issued also as CD
There are no comments on this title.